Submission of Revised Outcome of the EGM of the Company held on 3rd June, 2025 at 03:00 PM through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited held an Extra-Ordinary General Meeting (EGM) on 3rd June 2025 via video conferencing from 3:02 PM to 3:10 PM, chaired by Managing Director Mr. Bhumishth Patel. Five resolutions were put to members, including an increase in authorised share capital and alteration of the capital clause of the Memorandum of Association (Ordinary Resolution), two proposals for issue and allotment of equity shares on a preferential basis (Special Resolutions), alteration of the object clause of the Memorandum of Association (Special Resolution), and regularization of Ms. Pushpa Joshi (DIN: 06838093) as a Non-Executive and Independent Director (Special Resolution). The company has stated that e-voting results will be declared within two working days and shared with the stock exchange. This is a revised filing submitted to BSE under Regulation 30 of the SEBI LODR Regulations, 2015.
The preferential allotments and authorised capital expansion suggest the company is preparing to raise funds or issue shares to specific investors, which may lead to dilution for existing shareholders. The change in the object clause indicates a possible shift in business focus, and the appointment of a new independent director strengthens board oversight.